Analysis of intron 4 of the p53 gene in human cutaneous melanoma

Gene

Volumn 176, Issue 1-2, 1996, Pages 259-262

  Shamsher, Monee ^b   Montano, Ximena ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NONE

Author keywords

Human cutaneous melanoma; Intron 4; P53 gene; Transcription factor binding

Indexed keywords

PROTEIN P53; TRANSCRIPTION FACTOR;

ARTICLE; CELL LINE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DATA BASE; DNA SEQUENCE; EMBRYO; HUMAN; HUMAN CELL; INTRON; MELANOMA; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION;

EID: 0030591779     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-1119(96)00000-5     Document Type: Article

References (13)

1. Albino, A.P., Vidal, M.J., McNutt, N.S., Shea, C.R., Prieto, V.G., Nanus, D.M., Palmer, J.M. and Hayward, N.K. (1994) Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res. 4, 35-45.
2. Beenken, S.W., Karsenty, G., Raycroft, L. and Lozano, G. (1991) An intron binding protein is required for transformation ability of p53. Nucleic Acids Res. 19, 4747-4752.
3. El-Deiry, W.S., Kern, S.E., Pietenpol, J.A. and Kinzler, K.W. (1992) Definition of a consensus binding site for p53. Nature Genet. 1, 45-49.
4. Faisst, S. and Meyer, S. (1992) Compilation of vertebrate encoded transcription factors. Nucleic Acids Res. 20, 3-26.
5. Fuch, R. (1994) Predicting protein function: A versatile tool for the Apple Macintosh. Comput. Appl. Biosci. 10, 171-178.
6. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers. Science 253, 49-53.
7. Huang, D.-H., Horikoshi, M. and Roeder, R.G. (1988) Activation of the adenovirus Ella late promoter by a single point mutation which enhances binding of transcription factor IID. J. Biol. Chem. 263, 12596-12601.
8. Kim, S.-J., Denhez, F., Kim, K.Y., Holt, J.T., Sporn, M.B. and Roberts, A.B. (1989) Activation of the second promoter of the transforming growth factor-β1 gene by transforming growth factor-β1 and phorbol ester occurs through the same target sequences. J. Biol. Chem. 264, 19373-19378.
9. Lenardo, M.J. and Baltimore, D. (1989) NF-κB a pleitropic mediator of inducible and tissue specific gene control. Cell 58, 227-229.
10. Levine, A.J., Momand, J. and Finlay, C.A. (1991) The p53 tumor suppressor gene. Nature 351, 453-456.
11. Lozano, G. and Levine A.J. (1991) Tissue specific expression of p53 in transgenic mice is regulated by intron sequences. Mol. Carcin. 4, 3-9.
12. Martin-Zanca, D., Hughes, S. and Barbacid, M. (1986) A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 319, 743-748.
13. Montano, X., Shamsher, M., Whitehead, P., Dawson, K. and Newton, J. (1994) Analysis of p53 in human cutaneous melanoma cell lines. Oncogene 9, 1455-1459.